Defective Intestinal Mucin-Type O-Glycosylation Causes Spontaneous Colitis-Associated Cancer in Mice.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Gastroenterology

• Publication date

  2016-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1053/j.gastro.2016.03.039PMID 27059389PMCID PMC5068133
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Critical Role for the DNA Sensor AIM2 in Stem Cell Proliferation and Cancer.

  2015cited by this paper
• The complex role of inflammasomes in the pathogenesis of Inflammatory Bowel Diseases - lessons learned from experimental models.

  2014cited by this paper
• Immature truncated O-glycophenotype of cancer directly induces oncogenic features

  2014cited by this paper
• NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion.

  2014cited by this paper
• Mechanisms and functions of inflammasomes.

  2014cited by this paper
• Inflammasome activation plays an important role in the development of spontaneous colitis

  2014cited by this paper
• Caspase-11 is expressed in the colonic mucosa and protects against dextran sodium sulphate-induced colitis

  2014cited by this paper
• Epithelial Cell Extrusion Leads to Breaches in the Intestinal Epithelium

  2013cited by this paper
• Initiation of GalNAc-type O-glycosylation in the endoplasmic reticulum promotes cancer cell invasiveness

  2013cited by this paper
• ASC-associated inflammation promotes cecal tumorigenesis in aryl hydrocarbon receptor-deficient mice.

  2013cited by this paper
• IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine

  2012cited by this paper
• Chronic epithelial NF-κB activation accelerates APC loss and intestinal tumor initiation through iNOS up-regulation

  2012cited by this paper
• IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4+ Th17 cells

  2012cited by this paper
• Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis.

  2012cited by this paper
• Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota

  2012cited by this paper
• Altered O‐glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammation

  2011cited by this paper
• Inflammasomes and Intestinal Tumorigenesis.

  2011cited by this paper
• Innate immune mechanisms of colitis and colitis-associated colorectal cancer

  2011cited by this paper
• Intestinal inflammation and cancer.

  2011cited by this paper
• Non-canonical inflammasome activation targets caspase-11

  2011cited by this paper
• Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice.

  2011cited by this paper
• The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis.

  2010cited by this paper
• Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4

  2010cited by this paper
• Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases.

  2010cited by this paper
• Nitric oxide and TNF-α trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice

  2009cited by this paper
• Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells.

  2009cited by this paper
• Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice.

  2008cited by this paper
• The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria

  2008cited by this paper
• Local and systemic interleukin‐18 and interleukin‐18‐binding protein in children with inflammatory bowel disease

  2008cited by this paper
• Aberrant Mucin Assembly in Mice Causes Endoplasmic Reticulum Stress and Spontaneous Inflammation Resembling Ulcerative Colitis

  2008cited by this paper
• An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression

  2007cited by this paper
• Increased susceptibility to colitis and colorectal tumors in mice lacking core 3–derived O-glycans

  2007cited by this paper
• Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection.

  2006cited by this paper
• Solid-phase permethylation of glycans for mass spectrometric analysis.

  2005cited by this paper
• Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells.

  2005cited by this paper
• A unique molecular chaperone Cosmc required for activity of the mammalian core 1 β3-galactosyltransferase

  2002cited by this paper
• IL-1 beta -converting enzyme (caspase-1) in intestinal inflammation.

  2001cited by this paper
• Microscale nonreductive release of O-linked glycans for subsequent analysis through MALDI mass spectrometry and capillary electrophoresis.

  2001cited by this paper
• IL-1β-converting enzyme (caspase-1) in intestinal inflammation

  2001cited by this paper
• Bioactive IL-18 expression is up-regulated in Crohn's disease.

  1999cited by this paper
• Imbalance of the interleukin 1 system in colonic mucosa--association with intestinal inflammation and interleukin 1 receptor antagonist [corrected] genotype 2.

  1997cited by this paper
• Imbalance of the interleukin 1 system in colonic mucosa—association with intestinal inflammation and interleukin 1 receptor agonist genotype 2

  1997cited by this paper
• Sialosyl-Tn antigen is prevalent and precedes dysplasia in ulcerative colitis: a retrospective case-control study.

  1996cited by this paper
• Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.

  1996cited by this paper
• Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice.

  1995cited by this paper
• Ulcerative colitis and adenocarcinoma of the colon in Gαi2-deficient mice

  1995cited by this paper
• Sialosyl-Tn antigen: initial report of a new marker of malignant progression in long-standing ulcerative colitis.

  1995cited by this paper
• Nonselective and efficient fluorescent labeling of glycans using 2-amino benzamide and anthranilic acid.

  1995cited by this paper
• A genetic model for colorectal tumorigenesis.

  1990cited by this paper
• T and Tn, general carcinoma autoantigens.

  1984cited by this paper

• Neobavaisoflavone, a functional metabolite derived from valnemulin, ameliorates DSS-induced ulcerative colitis through activation of the AMPK signaling pathway.

  2026cites this paper
• Mucosal glycans: key drivers of the development of inflammatory bowel disease and a potential new therapeutic target.

  2026cites this paper
• Deletion of Core 1 β3GalT-specific Molecular Chaperone (Cosmc) in murine intestinal epithelia leads to major alterations in glycocalyx and tumorigenesis.

  2026cites this paper
• Goblet cell-expressed microprotein FXYD3 determines gut homeostasis by maintaining mucus barrier integrity.

  2025cites this paper
• Microbiota and inflammatory bowel disease: the dual effect mechanism of polysaccharide therapy

  2025cites this paper
• Neuromuscular Defects in a Drosophila Model of the Congenital Disorder of Glycosylation SLC35A2-CDG

  2025cites this paper
• Gut microbiota as a mediator of cancer development and management: From colitis to colitis-associated dysplasia and carcinoma.

  2025cites this paper
• The Role of Lactiplantibacillus plantarum CGMCC9513 in Alleviating Colitis by Synergistic Enhancement of the Intestinal Barrier Through Modulating Gut Microbiota and Activating the Aryl Hydrocarbon Receptor.

  2025cites this paper
• β1,6-Selective Enzymatic N-Acetylglucosamination Catalyzed by the Family GH84 N-Acetyl-β-D-glucosaminidase from Bacteroides thetaiotaomicron and its Glycosyl Acceptor Specificity.

  2025cites this paper
• Bletilla oligosaccharides improved 5-fluorouracil-induced intestinal mucositis in mice by activating NF-κB signalling pathway and regulating intestinal microbiota

  2025cites this paper
• Charge matters: how flanking substrate charge modulates O-glycan Core elongation.

  2025cites this paper
• Cross-kingdom-mediated detection of intestinal protozoa through NLRP6.

  2025cites this paper
• HDAC inhibitors and IBD: Charting new approaches in disease management.

  2025cites this paper
• The evolving understanding of systemic mechanisms in organ-specific IgA nephropathy: a focus on gut-kidney crosstalk

  2025cites this paper
• Neutrophils: From Inflammatory Bowel Disease to Colitis-Associated Colorectal Cancer

  2025cites this paper
• Fine structural features of polysaccharides and gut microbiota Co-regulate mucin O-glycosylation: Mechanisms and advances

  2025cites this paper
• Intestinal Mucin Glycosylation: Structural Regulation, Homeostasis Maintenance and Disease Association

  2025influential citation
• The protective effect of Amitriptyline on experimental colitis through inhibiting TLR4/MD2 signaling pathway.

  2024cites this paper
• Galacto-oligosaccharides regulate intestinal mucosal sialylation to counteract antibiotic-induced mucin dysbiosis.

  2024cites this paper
• Inflammasome activation links enteric Salmonella Typhimurium infection to a rapid, cytokine-dependent increase in intestinal mucin release

  2024cites this paper
• Gut microbial metabolic flux disorder in hypertension

  2024cites this paper
• IL-22 promotes mucin-type O-glycosylation and MATH1+ cell-mediated amelioration of intestinal inflammation

  2024cites this paper
• Alginate Oligosaccharides Enhance Antioxidant Status and Intestinal Health by Modulating the Gut Microbiota in Weaned Piglets

  2024cites this paper
• Ablation of Intestinal Epithelial Sialylation Predisposes to Acute and Chronic Intestinal Inflammation in Mice

  2024influential citation
• Oxytocin Alleviates Colitis and Colitis-Associated Colorectal Tumorigenesis via Noncanonical Fucosylation

  2024cites this paper
• Characterizing the human intestinal chondroitin sulfate glycosaminoglycan sulfation signature in inflammatory bowel disease

  2024cites this paper
• Emerging cell and molecular targets for treating mucus hypersecretion in asthma.

  2024cites this paper
• High core 1β1,3-galactosyltransferase 1 expression is associated with poor prognosis and promotes cellular radioresistance in lung adenocarcinoma

  2024cites this paper
• Unraveling the role of C1GALT1 in abnormal glycosylation and colorectal cancer progression

  2024influential citation
• Transcription suppression of GABARAP mediated by lncRNA XIST-EZH2 interaction triggers caspase-11-dependent inflammatory injury in ulcerative colitis.

  2024cites this paper
• Preparation of O-Glycans from Mucins Using Hydrazine Treatment.

  2024cites this paper
• The regulation of intestinal microbiota and the intervention of Chinese herbal medicine in the treatment of ulcerative colitis

  2024cites this paper
• Mechanism of Nrf2 in the treatment of ulcerative colitis via regulating macrophage polarization.

  2023cites this paper
• Targeting Solid Cancers with a Cancer-Specific Monoclonal Antibody to Surface Expressed Aberrantly O-glycosylated Proteins

  2023cites this paper
• Sea cucumber chondroitin sulfate polysaccharides attenuate OVA-induced food allergy in BALB/c mice associated with gut microbiota metabolism and Treg cell differentiation.

  2023cites this paper
• Rhubarb polysaccharide and berberine co-assembled nanoparticles ameliorate ulcerative colitis by regulating the intestinal flora

  2023cites this paper
• Partially hydrolyzed guar gum increased colonic mucus layer in mice via succinate-mediated MUC2 production

  2023cites this paper
• Biochemical and structural basis of sialic acid utilization by gut microbes

  2023cites this paper
• Role of tumor cell sialylation in pancreatic cancer progression.

  2023cites this paper
• Modified Gegen Qinlian decoction ameliorates DSS-induced chronic colitis in mice by restoring the intestinal mucus barrier and inhibiting the activation of γδT17 cells.

  2023cites this paper
• Development of a 32-gene signature using machine learning for accurate prediction of inflammatory bowel disease

  2023cites this paper
• The gut commensal Blautia maintains colonic mucus function under low fiber consumption through short-chain fatty acid-mediated activation of Ffar2

  2023cites this paper
• Muc2 mucin o-glycosylation interacts with enteropathogenic Escherichia coli to influence the development of ulcerative colitis based on the NF-kB signaling pathway

  2023cites this paper
• Role of mucin glycosylation in the gut microbiota-brain axis of core 3 O-glycan deficient mice

  2023cites this paper
• C1GalT1 expression reciprocally controls tumour cell-cell and tumour-macrophage interactions mediated by galectin-3 and MGL with double impact on cancer development and progression

  2023cites this paper
• Oxytocin alleviated colitis and colitis-associated colorectal tumorigenesis by targeting fucosylated MUC2

  2023cites this paper
• Update and latest advances in mechanisms and management of colitis-associated colorectal cancer

  2023cites this paper
• The performance of Carbohydrate Antigen 125-Thomsen-nouveau and anti-Müllerian hormone combined with CA125, Human epididymis protein 4 and Risk of Malignancy Algorithm in diagnosis for patients with Epithelial ovarian cancer.

  2023cites this paper
• The gut mucus network: A dynamic liaison between microbes and the immune system.

  2023cites this paper
• IN VIVO MODELS OF MUCIN BIOSYNTHESIS AND FUNCTION.

  2022cites this paper
• Cellular Carcinogenesis: Role of Polarized Macrophages in Cancer Initiation

  2022cites this paper
• The barrier and beyond: Roles of intestinal mucus and mucin-type O-glycosylation in resistance and tolerance defense strategies guiding host-microbe symbiosis

  2022cites this paper
• Multi-omics unravel the compromised mucosal barrier function linked to aberrant mucin O-glycans in a pig model.

  2022cites this paper
• Mucin O-glycan-microbiota axis orchestrates gut homeostasis in a diarrheal pig model

  2022cites this paper
• Colon mucus in colorectal neoplasia and beyond

  2022cites this paper
• Update on the role of C1GALT1 in cancer

  2022cites this paper
• Dysregulation and prometastatic function of glycosyltransferase C1GALT1 modulated by cHP1BP3/ miR-1-3p axis in bladder cancer

  2022cites this paper
• Mucin-Type O-GalNAc Glycosylation in Health and Disease.

  2021cites this paper
• MUC4 enhances gemcitabine resistance and malignant behaviour in pancreatic cancer cells expressing cancer-associated short O-glycans.

  2021cites this paper
• Microbe–Mucus Interface in the Pathogenesis of Colorectal Cancer

  2021cites this paper
• The effects of diet and gut microbiota on the regulation of intestinal mucin glycosylation.

  2021cites this paper
• ANALYSIS OF CARBOHYDRATES AND GLYCOCONJUGATES BY MATRIX-ASSISTED LASER DESORPTION/IONIZATION MASS SPECTROMETRY: AN UPDATE FOR 2015-2016.

  2021cites this paper
• PPARγ: The Central Mucus Barrier Coordinator in Ulcerative Colitis.

  2021cites this paper
• Dietary Fucose Affects Macrophage Polarization and Reproductive Performance in Mice

  2021cites this paper
• It takes a village: microbiota, parainflammation, paligenosis and bystander effects in colorectal cancer initiation.

  2021cites this paper
• Mapping of truncated O-glycans in cancers of epithelial and non-epithelial origin

  2021cites this paper
• Gut microbiota mediates the effects of inulin on enhancing sulfomucin production and mucosal barrier function in a pig model.

  2021cites this paper
• Dietary Barley Leaf Mitigates Tumorigenesis in Experimental Colitis-Associated Colorectal Cancer

  2021cites this paper
• Mucin-Type O-Glycans: Barrier, Microbiota, and Immune Anchors in Inflammatory Bowel Disease

  2021cites this paper
• Finding the sweet spot: glycosylation mediated regulation of intestinal inflammation

  2021cites this paper
• The Role of Microbiome in Cancer Cell Stimulation and Therapy

  2021cites this paper
• MUC2 and related bacterial factors: Therapeutic targets for ulcerative colitis

  2021cites this paper
• Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer

  2021cites this paper
• Glycosylation changes in inflammatory diseases.

  2020cites this paper
• ST6GalNAc‐I promotes lung cancer metastasis by altering MUC5AC sialylation

  2020cites this paper
• Proximal colon–derived O-glycosylated mucus encapsulates and modulates the microbiota

  2020cites this paper
• Elevated miR‐124‐3p in the aging colon disrupts mucus barrier and increases susceptibility to colitis by targeting T‐synthase

  2020cites this paper
• Upconversion optogenetic micro-nanosystem optically controls the secretion of light-responsive bacteria for systemic immunity regulation

  2020cites this paper
• Tripartite relationship between gut microbiota, intestinal mucus and dietary fibers: towards preventive strategies against enteric infections.

  2020cites this paper
• Mucins in Intestinal Mucosal Defense and Inflammation: Learning From Clinical and Experimental Studies

  2020cites this paper
• Bacterial colonization and TH17 immunity are shaped by intestinal sialylation in neonatal mice.

  2020cites this paper
• An indisputable role of NHE8 in mucosal protection.

  2020cites this paper
• Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD

  2020cites this paper
• Role of Inflammation in Pathophysiology of Colonic Disease: An Update

  2020cites this paper
• O-glycan recognition and function in mice and human cancers.

  2020cites this paper
• A Systematic Review on the Implications of O-linked Glycan Branching and Truncating Enzymes on Cancer Progression and Metastasis

  2020influential citation
• Experimental models to study intestinal microbes-mucus interactions in health and disease.

  2019cites this paper
• Genome-wide Analysis Reveals DNA Methylation Alterations in Obesity Associated with High Risk of Colorectal Cancer

  2019cites this paper
• Loss of the disease-associated glycosyltransferase Galnt3 alters Muc10 glycosylation and the composition of the oral microbiome

  2019cites this paper
• Tn antigen promotes human colorectal cancer metastasis via H‐Ras mediated epithelial‐mesenchymal transition activation

  2019cites this paper
• Core 1–derived mucin-type O-glycosylation protects against spontaneous gastritis and gastric cancer

  2019cites this paper
• protein glycosylation as a diagnostic and prognostic marker of chronic inflammatory gastrointestinal and liver diseases.

  2019cites this paper
• The structure of the colorectal cancer-associated enzyme GalNAc-T12 reveals how nonconserved residues dictate its function

  2019cites this paper
• Inflammasomes in Colitis and Colorectal Cancer: Mechanism of Action and Therapies

  2019cites this paper
• Decreased expression of MUC2 due to a decrease in the expression of lectins and apoptotic defects in colitis patients

  2019cites this paper
• Core fucosylated glycan-dependent inhibitory effect of QSOX1-S on invasion and metastasis of hepatocellular carcinoma

  2019cites this paper
• A detection and quantification label-free tool to speed up downstream processing of model mucins

  2018cites this paper
• Correlation of Tn antigen expression with mucins in Chinese patients with colorectal cancer.

  2018cites this paper
• Microbiome and Colorectal Cancer

  2018cites this paper
• A molecular switch orchestrates enzyme specificity and secretory granule morphology

  2018cites this paper